TAVR Cases. Disclosures 2/17/2018. February 17, :15 3:30 PM 15 min

Similar documents
TAVR: Echo Measurements Pre, Post And Intra Procedure

How Do I Evaluate a Patient Being Considered for TAVR? Sunday, February 14, :00 11:25 PM 25 min

Percutaneous Therapy for Calcific Mitral Valve Disease

Stress Testing in Valvular Disease

An Update on the Edwards TAVR Results. Zvonimir Krajcer, MD Director, Peripheral Intervention Texas Heart Institute at St.

Comments restricted to Sapien and Corevalve 9/12/2016. Disclosures: Core Lab contracts with Edwards Lifesciences, Middlepeak, Medtronic

PVL Assessment. Is paravalvular regurgitation after TAVR still an important consideration in 2018?

TAVR TTE INTERROGATION BY ALAN MATTHEWS

Valve Replacement without a Scalpel Transcatheter Aortic Valve Replacement (TAVR) Charles T. Klodell, M.D.

Echo Assessment Pre-TAVI

Transcatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data

Diseases of Aorta: Marfan, Dissection, Atheroma

HOW IMPORTANT ARE THESE ECHO MEASUREMENTS ANYWAY?

Aortic Stenosis Background and Breakthroughs in Treatment: TAVR Update

Prosthetic valve dysfunction: stenosis or regurgitation

Prosthesis-Patient Mismatch or Prosthetic Valve Stenosis?

TAVR: Review of the Robust Data from Randomized Trials

Outline. EuroScore II. Society of Thoracic Surgeons Score. EuroScore II

Echo evaluation for TAVR. From the General Cardiologist to the Interventional Echocardiologist

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know

Aortic Valve Stenosis: When stress TTE and/or TEE is required to make the diagnosis and guide treatment

Nouvelles indications/ Nouvelles valves

Transcatheter Aortic Valve Replacement

Procedural Guidance of TAVR: How to Assure it Goes Right and What to Do If It Doesn t

Echo in Asymptomatic Mitral and Aortic Regurgitation

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More?

Left Ventricular Assist Device: What Should I Report?

AS with reduced LV ejection fraction: Contractile reserve should be systematically assessed: PRO

New Cardiovascular Devices and Interventions: Non-Contrast MRI for TAVR Abhishek Chaturvedi Assistant Professor. Cardiothoracic Radiology

STRUCTURAL. aortic stenosis, transcatheter aortic valve replacement

Culprit vs Multivalve Transcatheter Intervention

TAVR in 2020: What is Next!!!!

*Core lab for numerous trials, for which I receive no direct compensation from sponsors.

TAVR for low-risk patients in 2017: not so fast.

TAVR in Intermediate Risk Populations /Optimizing Systems for TAVR

TAVR SPRING 2017 The evolution of TAVR

Section 1: Initial Evaluation for Valvular Heart Disease Table 1: Initial Evaluation of an Asymptomatic Patient

Minimalist Transcatheter Aortic Valve Replacement (MA-TAVR)

PARAVALVULAR LEAK POST TAVR. Elements of Follow-up Post TAVR

Paravalvular Regurgitation is a Risk Factor Following TAVI

SAPIEN 3 Sizing Considerations:

Aortic Stenosis: Background

Transcatheter Valve Replacement: Current State in 2017

TEE guided TAVR using BASILICA technique in patient with stenotic Freestyle aortic bioprosthesis

Aortic Stenosis and TAVR TARUN NAGRANI, MD INTERVENTIONAL AND ENDOVASCULAR CARDIOLOGIST, SOMC

3D Printing & Echocardiography

Emergency TAVI: Does It Exist? Is the Risk Higher?

Edwards Sapien. Medtronic CoreValve. Inoperable FDA approved High risk: in trials. FDA approved

TAVR: Intermediate Risk Patients

Aortic Stenosis: UPDATE Anjan Sinha, MD Krannert Institute of Cardiology

TAVR today: High Risk, Intermediate Risk Population, and Valve in Valve Therapy

Indicator Mild Moderate Severe

DISCLOSURE. Relevant Financial Relationship(s) Off Label Usage. None. None

Transcatheter procedures of the future; expanding the treatment options for patients with severe aortic stenosis

Case Presentations TAVR: The Good Bad and The Ugly

Echocardiographic Evaluation of Aortic Valve Prosthesis

Boston, MA 2 Service Chief, Cardiovascular Imaging, Department of Radiology, Massachusetts General Hospital,

SAPIEN 3: Evaluation of a Balloon- Expandable Transcatheter Aortic Valve in High-Risk and Inoperable Patients With Aortic Stenosis One-Year Outcomes

Disclosures. LGH TAVR: Presentation Outline 2/2/2016. Updates in Transcatheter Aortic Valve Replacement (TAVR) and the LGH Experience

Subacute left ventricular outflow tract obstruction after transapical closure of a mitral paravalvular leak in the region of the aortomitral curtain

Debate: SAVR for Low-Risk Patients in 2017 is Obsolete AVR vs TAVI

Trend and Outcomes of Direct Transcatheter Aortic Valve Replacement from a Single-Center Experience

Valvular Heart Disease

Federico M Asch MD, FASE MedStar Heart and Vascular Institute Georgetown University Washington, DC

Outcomes in the Commercial Use of Self-expanding Prostheses in Transcatheter Aortic Valve Replacement: A Comparison of the Medtronic CoreValve and

3D Printing & Echocardiography

TAVR-Update Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central

Corrado Tamburino, MD, PhD

Optimal Imaging Technique Prior to TAVI -Echocardiography-

Neal Kleiman, MD Houston Methodist DeBakey Heart and Vascular Institute

Andrzej Ochala, MD Medical University of Silesia, Katowice, Poland

Low Gradient Severe? AS

ECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction

Successful Transfemoral Edwards Sapien Aortic. Valve Implantation in a Patient with Previous. Mitral Valve Replacement

Transcatheter Aortic Valve Replacement With the St. Jude Medical Portico Valve

Echocardiographic Evaluation of Mitral Valve Prostheses

New imaging modalities for assessment of TAVI procedure and results. R Dulgheru, MD Heart Valve Clinic CHU, Liege

Ian T. Meredith AM. MBBS, PhD, FRACP, FCSANZ, FACC, FAPSIC. Monash HEART, Monash Health & Monash University Melbourne, Australia

Aortic Stenosis: Open vs TAVR vs Nothing

King s Research Portal

Prosthesis-Patient Mismatch in High Risk Patients with Severe Aortic Stenosis in a Randomized Trial of a Self-Expanding Prosthesis

Structural Heart Disease Transcatheter Aortic Valve Replacement (TAVR)

TAVI Technology and Procedural Changes

The safety of introducing a new generation TAVR device: one departments experience from introducing a second generation repositionable TAVR

Echocardiographic evaluation of mitral stenosis

2/15/2018 DISCLOSURES OBJECTIVES. Consultant for BioSense Webster, a J&J Co. Aortic stenosis background. Short history of TAVR

Early Surgery in Asymptomatic Severe Aortic Stenosis Pros and Cons

Uncommon Doppler Echocardiographic Findings of Severe Pulmonic Insufficiency

TAVI and TAVR: Radical and Revolutionary: The Newest Insights for the CV Community and a Panel Discussion

Stage of Valvular AS. Outline 10/14/16. Low-flow and Other Challenges to the Assessment of Aortic Stenosis. Severe AS

7 th Conference of Transcatheter Heart Valve Therapies

Echocardiographic Evaluation of Aortic Valve Prosthesis

Mild paravalvular regurgitation is not an independent predictor of mortality following TAVI

THE PERCUTANEOUS MANAGEMENT OF VALVULAR HEART DISEASE DR JOHN RAWLINS CONSULTANT INTERVENTIONAL CARDIOLOGIST UNIVERSITY HOSPITAL SOUTHAMPTON

CARDIOLOGY GRAND ROUNDS

Vascular complications of embolized core valve

Potential conflicts of interest

Evolut R in bicuspid valve anatomies

Transcatheter Aortic Valve Replacement with Evolut-R

Is TAVI ready for prime time in: - Intermediate risk patients? - Low risk patients?

Transcription:

31 st Annual State of the Art Echocardiography San Diego, CA February 17, 2018 3:15 3:30 PM 15 min TAVR Cases Muhamed Sarić MD, PhD, MPA Director of Noninvasive Cardiology Echo Lab Associate Professor of Medicine Disclosures Speakers Bureau (Philips, Medtronic) Advisory Board (Siemens) 1

First Let s Set the Stage TAVR Intraprocedural Echo Evaluation When.. Proper preprocedural TAVR valve sizing is done, and When newer generation TAVR valves are used, By a an experienced TAVR team TAVR procedure is typically uneventful Complications are relatively rare 2

What to Look For During TAVR on Echo? TAVR Valve Function Paravalvular Leak Complications Question Echo Type Should I use transesophageal echo (TEE) or transthoracic echo (TTE) during TAVR procedures? 3

NYU TAVR Program TEE vs. TTE Sep 1, 2011 Jan 21, 2018 NYU Sedation / TTE Experience NYU Pre-Sadation STS/TVR Registry Protocol (2011-2013) 2014 NYU Sedation Monsth 1-3 NYU Sedation Monsth 4-6 NYU Sedation Monsth 7-9 NYU Sedation Monsth 10-12 NYU Sedation Entire Year All Cases 55 12558 55 42 58 59 214 # of Sedation Cases 0 629 42 35 58 59 194 % Sedation Cases 0% 5% 76% 83% 100% 100% 91% Average LOS (days) 5.4 6.1 3.1 2.5 2.6 2.1 2.6 Median LOS (days) 5 5 2 2 2 2 2 Average Procedure Time (hh:mm) 2:37 1:19 1:30 1:33 1:23 1:20 1:21 In-hospital Mortality 5.5% 4.0% 3.6% 2.3% 0.0% 1.7% 1.9% NYU Sedation / TTE Program Decrease in length of stay and in-hospital mortality 4

TAVR Valve Function TAVR: Markers of Good Implantation Seal-Velocity-Shape (SVS) Triad Valve Seal / Regurgitation No significant paravalvular or transvalvular aortic regurgitation Valve Velocity / Gradient Vmax typically < 2.0 m/sec Valve Shape & Location Short axis: Circular rather than ovoid Long axis: Proximal end just a few millimeters in the LVOT If one or more suboptimal, consider: Repositioning TAVR valve (for self-expanding valves) Post-dilatation of TAVR valve with a balloon Implantation of another TAVR valve (valve-in-valve procedure) 5

TAVR Valve Velocity / Gradients Good TAVR Result Before TAVR Severe native valve stenosis Vmax = 4.3 m/sec Peak/Mean Gradient 74/43 mm Hg Time to peak gradient 140 msec (late peaking) After TAVR Minimal aortic valve gradients Vmax = 1.4 m/sec Peak/Mean Gradient 9/3 mm Hg Time to peak gradient 95 msec (early peaking) 6

TAVR Valve Shape & Location TAVR Valve Shape OPTIMAL SHAPE Circular 7

TAVR Valve Shape SUBOPTIMAL SHAPE Ovoid TAVR Valve Location OPTIMAL LOCATION No excessive protrusion into LVOT 8

TAVR Valve Location SUBOPTIMAL LOCATION Too deep into LVOT TAVR Valves Seal Location Self-expanding CoreValve Evolut Pro Balloon Expandable Sapien S3 9

TAVR: Procedural Steps with Self-Expanding Valve Step #1 Native Valve Visualization Step #2 Partial Deployment Step #3 Full Deployment Echo Parameters of Good TAVR : SEAL - No PVL : VELOCITY - Systolic Vmax < 2.0 m/s : SHAPE - Circular in cross-section TAVR: Procedural Steps with Balloon Expandable Valve Step #1 Native Valve Predilation Step #2 TAVR Valve Position Check Step #3 Full Deployment Echo Parameters of Good TAVR : SEAL - No PVL : VELOCITY - Systolic Vmax < 2.0 m/s : SHAPE - Circular in cross-section 10

Case Presentation 86-year-0ld woman Severe symptomatic high-gradient native aortic stenosis with preserved LVEF (ACC/AHA class D1) Undergoing transfemoral TAVR using a self-expanding bioprosthesis TTE is being used to for intraprocedural assessment NYU TAVR Cases by Age & Gender Sep 1, 2011 Jan 21, 2018 Men have a higher prevalence of trileaflet valve AS than women (1.3 fold relative increase) J Am Coll Cardiol. 2017;69:1523-1532 Men have a higher incidence of bicuspid aortic valve than women (male: female 3:1 ratio) Am J Cardiol 1984;53:849-855 11

Types of Aortic Stenosis Classic High-Gradient AS 65-85% Low-Gradient AS with Preserved EF 10-25% Low-Gradient AS with Diminished EF 5-10% Procedural Stage Self-expanding valve is partly deployed Ready for Seal-Velocity-Shape (SVS) Triad assessment 12

A5C View: TAVR Valve Seal Assessment TAVR Valve Velocity Check: Spectral Doppler 13

TAVR Valve Velocity Check: Spectral Doppler TAVR Valve Velocity Check: Spectral Doppler 14

Question How did the spectral tracings get inverted? Ultrasound System Keyboard 15

Ultrasound System Keyboard Spectral Doppler in A5C View: Right Side Up 16

TAVR Valve Shape Check: Noncircular Shape Solution: TAVR Valve Postdilation 17

Baseline Severe Native Aortic Stenosis Goof Inverted Spectral Doppler After Postdilation Normal TAVR Function Thank You! New York University Langone Medical Center 18